The goals of the Rich Lab are to identify novel therapeutic paradigms in the treatment of advanced cancers, primarily malignant brain tumors, through the understanding of a stem cell-like phenotype found in many cancers and core signal transduction pathways amenable to pharmacologic targeting. The aim is to better understand the clinical relevance of cancer stem cells and the interaction with the tumor microenvironment and underlying genetic driver mutations in human cancers.
More details about our lab's research